Skip to content
TrialScanner

NCT04059523

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3

Phase 1CompletedSLGLLead

Registry record

Lead sponsor
Sol-Gel Technologies, Ltd.
Conditions
Acne Vulgaris
Primary completion
Feb 6, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04059523 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04059523: MUSE Study to Evaluate the... | TrialScanner